Misoprostol is a synthetic prostaglandin E1 analog that plays a versatile role in medical practice due to its ability to induce uterine contractions and protect the stomach lining. It is widely recognized for its use in reproductive healthcare, particularly in combination with other agents, to facilitate medical termination of pregnancy under regulated supervision. By stimulating uterine muscle activity, it helps in cervical ripening and expulsion processes, making it valuable in obstetric applications such as induction of labor and management of miscarriage. Beyond reproductive medicine, Misoprostol is also employed in gastroenterology, where its protective effect on the gastric mucosa helps reduce the risk of ulcers associated with non-steroidal anti-inflammatory drug (NSAID) use. Its mechanism of action involves mimicking natural prostaglandins, thereby enhancing mucosal defenses in the stomach and promoting uterine contractility. This dual utility highlights its importance as a pharmaceutical agent that bridges both gastrointestinal and gynecological care. Overall, Misoprostol stands out as a clinically significant medication, offering non-surgical options in reproductive health and preventive strategies in ulcer management, always within the boundaries of strict medical guidance and regulatory compliance.